Related Experiment Video
Updated: Jul 15, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Patient expectations on lipid-lowering drugs
1Department of Public Health and Caring Sciences, Uppsala University, SE-75185 Uppsala, Sweden. per.lytsy@pubcare.uu.se
Patient Education and Counseling
|April 17, 2007
Summary
Patient expectations of statin treatment are influenced by communication and perceived health control, not solely medical history. Improving patient-physician communication can enhance treatment belief and adherence, potentially reducing coronary heart disease risk.
Area of Science:
- Cardiovascular Medicine
- Health Psychology
- Patient Adherence Research
Background:
- Statins are widely prescribed for cardiovascular disease prevention.
- Understanding patient expectations is crucial for treatment adherence and effectiveness.
Purpose of the Study:
- To assess patient expectations of statin treatment effectiveness.
- To identify factors associated with varying treatment beliefs in patients using statins.
Main Methods:
- A postal questionnaire survey was administered to 829 Swedish patients using statins.
- Data collected included health status, lifestyle, cardiovascular risk factors, and treatment expectations.
- Expected treatment benefit served as the primary outcome measure.
Main Results:
- Coronary heart disease history did not significantly impact treatment expectations.
- Patients with high cardiovascular disease risk reported slightly lower long-term (10-year) treatment effect expectations.
- Low satisfaction with treatment explanation and poor perceived health control correlated with more negative views on treatment benefits.
Conclusions:
- Patient expectations of statin therapy are influenced by the patient-physician relationship, social context, and perceived health control, rather than physician prescribing rationale alone.
- Enhanced patient-physician communication and tailored education are vital for improving belief in statin benefits and potentially reducing non-compliance and coronary heart disease risk.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...